A detailed history of Clear Street Markets LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 200 shares of ABBV stock, worth $36,228. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 800 75.0%
Holding current value
$36,228
Previous $137,000 71.53%
% of portfolio
0.01%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $98,304 - $119,598
-600 Reduced 75.0%
200 $39,000
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $6.22 Million - $7.27 Million
-40,200 Reduced 98.05%
800 $137,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $887,001 - $1.01 Million
5,550 Added 15.66%
41,000 $7.47 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $681,120 - $767,101
4,950 Added 16.23%
35,450 $5.49 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $748,771 - $866,813
-5,605 Reduced 15.52%
30,500 $4.55 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $97,527 - $121,366
736 Added 2.08%
36,105 $4.86 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $729,991 - $840,693
-5,048 Reduced 12.49%
35,369 $5.64 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $1.81 Million - $2.17 Million
-13,064 Reduced 24.43%
40,417 $6.53 Million
Q3 2022

Nov 02, 2022

BUY
$134.21 - $153.93 $3.51 Million - $4.03 Million
26,188 Added 95.95%
53,481 $7.18 Million
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $968,019 - $1.23 Million
-7,034 Reduced 20.49%
27,293 $4.18 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $9.21 Million - $11.4 Million
-69,791 Reduced 67.03%
34,327 $5.57 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $7.91 Million - $10 Million
73,618 Added 241.37%
104,118 $14.1 Million
Q3 2021

Oct 20, 2021

SELL
$106.4 - $120.78 $1.91 Million - $2.17 Million
-17,996 Reduced 37.11%
30,500 $3.29 Million
Q2 2021

Jul 19, 2021

BUY
$105.21 - $117.21 $2.71 Million - $3.02 Million
25,745 Added 113.16%
48,496 $5.46 Million
Q1 2021

Apr 14, 2021

SELL
$102.3 - $112.62 $4.14 Million - $4.56 Million
-40,502 Reduced 64.03%
22,751 $2.46 Million
Q4 2020

Feb 25, 2021

SELL
$80.49 - $108.67 $95,944 - $129,534
-1,192 Reduced 1.85%
63,253 $6.78 Million
Q3 2020

Oct 19, 2020

BUY
$85.91 - $100.83 $4.1 Million - $4.82 Million
47,772 Added 286.52%
64,445 $5.65 Million
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $301,624 - $403,617
-4,111 Reduced 19.78%
16,673 $1.64 Million
Q1 2020

Apr 28, 2020

SELL
$64.5 - $97.79 $6.58 Million - $9.98 Million
-102,073 Reduced 83.08%
20,784 $1.58 Million
Q4 2019

Jan 13, 2020

BUY
$72.13 - $90.25 $7.87 Million - $9.85 Million
109,157 Added 796.77%
122,857 $10.9 Million
Q3 2019

Oct 18, 2019

BUY
$62.98 - $75.72 $459,754 - $552,756
7,300 Added 114.06%
13,700 $1.04 Million
Q2 2019

Jul 16, 2019

SELL
$65.7 - $83.98 $321,930 - $411,502
-4,900 Reduced 43.36%
6,400 $465,000
Q1 2019

May 09, 2019

SELL
$77.14 - $90.79 $161,994 - $190,659
-2,100 Reduced 15.67%
11,300 $911,000
Q4 2018

Jan 23, 2019

SELL
$77.85 - $96.01 $124,559 - $153,616
-1,600 Reduced 10.67%
13,400 $1.24 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $577,915 - $642,460
6,500 Added 76.47%
15,000 $1.42 Million
Q2 2018

Jul 27, 2018

BUY
$89.78 - $106.23 $556,636 - $658,626
6,200 Added 269.57%
8,500 $788,000
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $3 Million - $4.02 Million
-32,600 Reduced 93.41%
2,300 $218,000
Q4 2017

Feb 01, 2018

BUY
$89.56 - $98.21 $2.5 Million - $2.74 Million
27,900 Added 398.57%
34,900 $3.38 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $488,949 - $624,540
7,000
7,000 $622,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.